InventisBio Co., Limited (SHA:688382)
China
· Delayed Price · Currency is CNY 22.20
+0.01 (0.05%)
At close: Apr 29, 2026
InventisBio Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 1,381 | 1,586 | 1,919 | 2,235 | 724.25 | Upgrade
|
| Trading Asset Securities | 153.68 | 101.3 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 1,535 | 1,687 | 1,919 | 2,235 | 724.25 | Upgrade
|
| Cash Growth | -9.04% | -12.10% | -14.13% | 208.62% | -29.90% | Upgrade
|
| Accounts Receivable | 84.67 | 165.34 | 176.57 | - | - | Upgrade
|
| Other Receivables | 4.46 | 5.93 | 6.65 | 3.98 | 4.25 | Upgrade
|
| Receivables | 89.12 | 171.28 | 183.21 | 3.98 | 4.25 | Upgrade
|
| Other Current Assets | 27.52 | 11.69 | 20.46 | 26.28 | 12.95 | Upgrade
|
| Total Current Assets | 1,651 | 1,870 | 2,123 | 2,265 | 741.45 | Upgrade
|
| Property, Plant & Equipment | 30.07 | 44.82 | 30.38 | 47.14 | 44.02 | Upgrade
|
| Other Intangible Assets | 1.43 | 0.59 | 0.92 | 1.25 | 0.11 | Upgrade
|
| Long-Term Deferred Tax Assets | 3.19 | 3.44 | 2.9 | 6.22 | - | Upgrade
|
| Long-Term Deferred Charges | 10.01 | - | 1.05 | 4.4 | 8.42 | Upgrade
|
| Other Long-Term Assets | 7.92 | 1.86 | 3.9 | 23.35 | 6.02 | Upgrade
|
| Total Assets | 1,704 | 1,921 | 2,162 | 2,348 | 800.03 | Upgrade
|
| Accounts Payable | 115.48 | 59.96 | 72.52 | 62.25 | 64.22 | Upgrade
|
| Accrued Expenses | 24.82 | 21.62 | 28.86 | 36.19 | 25.71 | Upgrade
|
| Current Portion of Leases | 7.15 | 7.79 | 9 | 12.07 | 8.71 | Upgrade
|
| Current Unearned Revenue | - | - | 47.17 | - | - | Upgrade
|
| Other Current Liabilities | 1.45 | 0.61 | 0.72 | 0.51 | 0.22 | Upgrade
|
| Total Current Liabilities | 148.9 | 89.98 | 158.27 | 111.02 | 98.85 | Upgrade
|
| Long-Term Leases | 14.92 | 16.13 | 2.61 | 15.27 | 14.94 | Upgrade
|
| Long-Term Unearned Revenue | 0.48 | 0.48 | 0.88 | 0.4 | 1.2 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3.43 | 3.44 | 2.9 | 6.22 | - | Upgrade
|
| Total Liabilities | 167.73 | 110.03 | 164.67 | 132.9 | 115 | Upgrade
|
| Common Stock | 578.35 | 576.75 | 575 | 575 | 460 | Upgrade
|
| Additional Paid-In Capital | 3,832 | 3,791 | 3,738 | 3,671 | 1,773 | Upgrade
|
| Retained Earnings | -2,862 | -2,545 | -2,305 | -2,021 | -1,537 | Upgrade
|
| Comprehensive Income & Other | -12.41 | -11.9 | -10.74 | -10.4 | -10.79 | Upgrade
|
| Shareholders' Equity | 1,536 | 1,811 | 1,998 | 2,215 | 685.03 | Upgrade
|
| Total Liabilities & Equity | 1,704 | 1,921 | 2,162 | 2,348 | 800.03 | Upgrade
|
| Total Debt | 22.07 | 23.92 | 11.62 | 27.34 | 23.66 | Upgrade
|
| Net Cash (Debt) | 1,513 | 1,663 | 1,908 | 2,208 | 700.6 | Upgrade
|
| Net Cash Growth | -9.06% | -12.82% | -13.59% | 215.14% | -32.20% | Upgrade
|
| Net Cash Per Share | 2.63 | 2.91 | 3.32 | 4.34 | 1.53 | Upgrade
|
| Filing Date Shares Outstanding | 578.35 | 576.75 | 575 | 575 | 460 | Upgrade
|
| Total Common Shares Outstanding | 578.35 | 576.75 | 575 | 575 | 460 | Upgrade
|
| Working Capital | 1,502 | 1,780 | 1,965 | 2,154 | 642.6 | Upgrade
|
| Book Value Per Share | 2.66 | 3.14 | 3.47 | 3.85 | 1.49 | Upgrade
|
| Tangible Book Value | 1,535 | 1,810 | 1,997 | 2,214 | 684.92 | Upgrade
|
| Tangible Book Value Per Share | 2.65 | 3.14 | 3.47 | 3.85 | 1.49 | Upgrade
|
| Machinery | 32.86 | 32.55 | 32.04 | 27.07 | 23.91 | Upgrade
|
| Construction In Progress | - | 6.47 | 0.5 | 2.58 | 1.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.